Concepedia
Statistics
Publications
17
Citations
2.6K
H-Index
15
Active since
2015
Affiliations
Gilead Sciences (United States)(Current)
Texas Liver Institute
The University of Texas Health Science Center at San Antonio
Inova Fairfax Hospital
University of California San Diego
C. Stephen Djedjos is an author at Gilead Sciences (United States) specializing in medicine, pathology, and hepatology fibrosis.
Top concepts
MedicinePathologyHepatologyLiver PhysiologyHepatology FibrosisHealthFibrosisPharmacologyMetabolic Associated SteatohepatitisCirrhosis
Publications per year
2015–2020
The ASK1 inhibitor selonsertib in patients with nonalcoholic steatohepatitis: A randomized, phase 2 trial
Rohit Loomba, Eric Lawitz, Parvez Mantry et al. · Hepatology · 2017 · 541 citations · Full text
Collagen Content, Pathology, Cell Death +17
Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials
Stephen A. Harrison, Vincent Wai‐Sun Wong, Takeshi Okanoue et al. · Journal of Hepatology · 2020 · 438 citations
Fibrosis, Hepatology, Liver Physiology +9
The Natural History of Advanced Fibrosis Due to Nonalcoholic Steatohepatitis: Data From the Simtuzumab Trials
Arun J. Sanyal, Stephen A. Harrison, Vlad Ratziu et al. · Hepatology · 2019 · 361 citations
Cilofexor, a Nonsteroidal FXR Agonist, in Patients With Noncirrhotic NASH: A Phase 2 Randomized Controlled Trial
Keyur Patel, Stephen A. Harrison, Magdy Elkhashab et al. · Hepatology · 2020 · 311 citations
Noninvasive Tests Accurately Identify Advanced Fibrosis due to NASH: Baseline Data From the STELLAR Trials
Quentin M. Anstee, Eric Lawitz, Naim Alkhouri et al. · Hepatology · 2019 · 258 citations
1–5 of 17